How to Use / Administration Methods
Subcutaneous injection represents the standard and most effective administration route for Thymosin Alpha 1. The peptide demonstrates poor oral bioavailability due to gastrointestinal degradation, making parenteral administration necessary.
Injection Technique: Using an insulin syringe (29-31 gauge, 0.5-1 mL capacity), inject into subcutaneous fat tissue at a 45-90 degree angle. Preferred sites include the abdominal region (avoiding the navel by 2 inches), the anterior thigh, and the posterior upper arm. Rotate injection sites to prevent lipodystrophy.
Timing: Ta1 can be administered at any time of day without regard to meals. Some prefer morning administration to align with natural circadian immune rhythms, though clinical evidence does not mandate specific timing.
Injection Frequency: Maintain consistent scheduling (e.g., Monday/Thursday or Tuesday/Friday for twice-weekly protocols) to sustain stable peptide exposure and immune modulation.
Reconstitution, Storage & Prep
Thymosin Alpha 1 typically arrives as a lyophilized (freeze-dried) powder requiring reconstitution before use.
Reconstitution: Using bacteriostatic water (preferred for multi-dose vials) or sterile water (for single-use), inject the diluent slowly down the vial's inner wall to prevent peptide degradation from agitation. Allow the powder to dissolve naturally over 1-2 minutes; do not shake. A typical reconstitution uses 5 mL of bacteriostatic water per 5 mg vial, yielding a concentration of 1 mg/mL.
Storage: Unreconstituted lyophilized powder remains stable at room temperature for extended periods but benefits from refrigeration (2-8°C) for long-term storage. Once reconstituted, store refrigerated and use within 28-30 days. Never freeze reconstituted peptide solutions. Protect from light exposure.
Preparation: Calculate injection volume based on reconstitution concentration and desired dose. For example, a 5 mg vial reconstituted with 5 mL bacteriostatic water yields 1 mg/mL; a 1.6 mg dose requires 1.6 mL.